Please assess the completion status of the following clinical trial:

Trial Title: Behavioral & Nutritional Treatment to Help CF Preschoolers Grow

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* confirmed diagnosis of cystic fibrosis based upon 2 of the following: a. sweat chloride by quantitative pilocarpine electrophoresis ≥60 milliequivalent/Liter (mEq/L), b. two clinical features consistent with CF, or c. genetic testing demonstrating two mutations associated with CF~* confirmation of pancreatic insufficiency based upon fecal elastase of ≤ 100 micrograms per gram of stool (or an undetectable level)~* age at enrollment to the trial of 2.0 years to 6.0 years~* at least 6 months post CF diagnosis~* consuming an unrestricted fat diet~Exclusion Criteria:~* diagnosis of developmental delay (i.e., autism, cerebral palsy, or mental retardation)~* receiving supplemental enteral nutrition via nasogastric tube, gastrostomy, or total parenteral nutrition~* diagnosed with another disease/condition (e.g., insulin dependent diabetes, congenital heart disease, significant renal disease, history of bowel resection or short bowel syndrome, colonic strictures) known to affect growth~* taking a medication (e.g., insulin, growth hormone, chronic use of systemic steroids) known to affect growth~* screening assessment shows genetic potential for height as acceptable according to the 2001 Consensus Conference guidelines and diet diary indicates daily Dietary Reference Intake (DRI) of energy average of 140% or greater (DRI of 100% will be determined as the estimated energy requirement \[EER\] based upon the child's age, gender, and an active physical activity level~* weight z score (age and gender adjusted) of \> 1.0~* prior participation in the pilot intervention studies conducted by the PI during the prior period of R01 funding or current participation in an intervention trial conducted by the Cystic Fibrosis Therapeutics Development Network.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 6 Years
- Healthy Volunteers: f

Study Arms:
- Behavioral and Nutrition Treatment (Type: EXPERIMENTAL): The behavioral and nutrition treatment combines individualized nutritional counseling that targeted increasing energy and fat intake and parent training in behavioral child-management skills based on social learning theory to improve meal-time behaviors.
- Education and Attention Control (Type: ACTIVE_COMPARATOR): The education and attention control treatment provides education and served as a behavioral placebo in terms of controlling for attention and contact frequency provided. Families are provided with information including general nutrition, enzyme therapy, respiratory infection control, and typical child development anticipatory guidance and safety for preschool- aged children.

Based on this trial design, predict the completion outcome and termination type (if applicable).